PTK2 and familial pancreatic carcinoma: While cotreatment with a FAK inhibitor and gemcitabine showed increased efficacy in WTAP-expressing pancreatic cancer cells compared with the use of either therapy alone58, this study did not test if the same results occur in vivo.